• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Army’s COVID-19 vaccine may hold key to beating coronavirus mutations

Mary Wilson

New member
Jan. 14, 2021 at 2:30 am Updated Jan. 14, 2021 at 4:02 am
By Michael Wilner and Tara Copp

WASHINGTON — Scientists at the Walter Reed Army Research Institute have promising new data indicating their vaccine will work against significant mutations of COVID-19, as well as entirely different coronaviruses, an achievement that other vaccines so far have not accomplished.

The data has yet to be peer reviewed. But the Army lab is hopeful that a pan-coronavirus vaccine is achievable after testing the drug on SARS, a coronavirus that emerged in 2003 with significant biological differences from the current pandemic disease known as SARS-CoV-2.

Tests of the vaccine against both SARS as well as emerging variants of COVID-19 have shown “very good responses,” said Dr. Kayvon Modjarrad, director of Walter Reed’s Emerging Infectious Diseases Branch.

... The Walter Reed vaccine — named SpFN — differs from other vaccines in that it uses a soccer ball-shaped protein, allowing scientists to harness the spikes of multiple coronavirus strains on 24 different faces of the protein.

https://www.seattletimes.com/nation...ay-hold-key-to-beating-coronavirus-mutations/
 
Back
Top Bottom